Search research articles
Contact Us
Filters
Showing results (121-130 of 353) with videos related to
Page
of 36
Sort By:
Health Services Research
|
January 31, 2009
Variation in drug prices at pharmacies: are prices higher in poorer areas?
Walid F Gellad, Niteesh K Choudhry, Mark W Friedberg, et al.
Cancer
|
August 28, 2003
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity
Jonathan W Friedberg, Donna Neuberg, Helen Kim, et al.
Annals of Internal Medicine
|
July 1, 2014
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study
Jane C Weeks, Hajime Uno, Nathan Taback, et al.
Plos One
|
July 27, 2023
Prevalence and appropriateness of in-person versus not-in-person ambulatory antibiotic prescribing in an integrated academic health system: A cohort study
Tiffany Brown, Ji Young Lee, Adriana Guzman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2016
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma
Patrick M Reagan, Andrea Baran, Jennifer L Kelly, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736
Deborah M Stephens, Hongli Li, Michael L LeBlanc, et al.
Joint Commission Journal on Quality and Patient Safety
|
April 5, 2019
Use of Internal Performance Measurement to Guide Improvement Within Medical Groups
Peggy G Chen, Michael I Harrison, Linda R Bergofsky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 31, 2016
Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse
Sughosh Dhakal, James E Bates, Carla Casulo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 29, 2018
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma
Rachel J David, Andrea Baran, Kah Poh Loh, et al.
Page
of 36
Search research articles
Search
Showing results (121-130 of 353) with videos related to
Sort By:
Page
of 36
Health Services Research
|
January 31, 2009
Variation in drug prices at pharmacies: are prices higher in poorer areas?
Walid F Gellad, Niteesh K Choudhry, Mark W Friedberg, et al.
Cancer
|
August 28, 2003
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity
Jonathan W Friedberg, Donna Neuberg, Helen Kim, et al.
Annals of Internal Medicine
|
July 1, 2014
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study
Jane C Weeks, Hajime Uno, Nathan Taback, et al.
Plos One
|
July 27, 2023
Prevalence and appropriateness of in-person versus not-in-person ambulatory antibiotic prescribing in an integrated academic health system: A cohort study
Tiffany Brown, Ji Young Lee, Adriana Guzman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2016
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma
Patrick M Reagan, Andrea Baran, Jennifer L Kelly, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736
Deborah M Stephens, Hongli Li, Michael L LeBlanc, et al.
Joint Commission Journal on Quality and Patient Safety
|
April 5, 2019
Use of Internal Performance Measurement to Guide Improvement Within Medical Groups
Peggy G Chen, Michael I Harrison, Linda R Bergofsky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 31, 2016
Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse
Sughosh Dhakal, James E Bates, Carla Casulo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 29, 2018
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma
Rachel J David, Andrea Baran, Kah Poh Loh, et al.
Page
of 36